Real-World Management of Thyroid Cancer with TRK Inhibitors

Ezra Cohen, MD, FRCPSC, FASCO; Mary Jo Fidler, MD

Video Categories: NTRK Gene Fusions

Dr Ezra Cohen of UC San Diego, La Jolla, CA, and Dr Mary Fidler of Rush University Medical Center, Chicago, IL, recount their clinical experiences and the journeys of patients treated with TRK inhibitors for thyroid cancer.

March 31, 2015

New Targets = Better Standard of Care

Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.

December 3, 2013

Basal Cell Carcinoma Case Studies in Hedgehog Pathway Inhibition

In this final WCMC clinical commentary entitled, The Impact of Hedgehog Pathway Inhibitors on the Management of Patients with Basal Cell Carcinoma, Joel Claveau, MD, CSPQ, FRCPC; Dirk Schadendorf, MD; Nicole Basset-Seguin, MD, PhD and Aleksandar Sekulic, MD, PhD discuss how Hedgehog Pathway Inhibitors opened a new chapter of treatment [ Read More ]